Diameter Health raises USD 9.6 million in series A-1 funding round
Category: #health  By Pankaj Singh  Date: 2019-04-11
  • share
  • Twitter
  • Facebook
  • LinkedIn

Diameter Health raises USD 9.6 million in series A-1 funding round
  • A new investor Optum Ventures, an independent venture fund of Optum, led the investment round
     
  • The new funding would support the company’s growth along with its commercial resources, cloud delivery, and additional development

Diameter Health, a clinical data integration provider, has reportedly announced that it has raised USD 9.6 million in series A-1 funding round. As per trusted sources, a new investor Optum Ventures, an independent venture fund of Optum, led the investment round.

Reportedly, Optum Ventures joins existing investors of the firm including LRV Health, Excelerate Health Ventures, Connecticut Innovations, and Activate Venture Partners.

Chief Executive Officer of Diameter Health, Eric Roscow was reportedly quoted saying that the volume of clinical data being exchanged has increased substantially over the last decade and firms operating in the healthcare sector are grappling with how to turn the volume of data into a valuable and useful asset. Diameter Health’s partnership with Optum Ventures would accelerate the company’s ability to meet the industry demand for technology which makes clinical data actionable at scale, Roscow further added.

Diameter Health has created a high-end technology that cleans multisource clinical data with the focus toward actionable insight for healthcare institutions.

According to the press release by Diameter Health, the Office of the National Coordinator for Healthcare IT and the National Committee for Quality Assurance (NCQA) have certified the technology. The new funding would support the company’s growth along with its commercial resources, cloud delivery, and additional development.

General Partner at LRV Health, Tripp Peake reportedly commented that the firm is excited to have Optum Ventures as part of the Diameter Health team. Peake further added that access to clinical data has limited value if the data isn’t reliable and that Diameter Health is leveraging on the market need for actionable, normalized, and clean data from disparate systems and sources. Reportedly, this need for data would continue to increase as clinical data is increasingly leverage throughout the healthcare system.



About Author

Pankaj Singh

Email: [email protected]ters.com   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
By Pankaj Singh

While top-notch companies are racing to develop a vaccine for COVID-19, it looks like the United States has secured almost all of the world’s supply of interim drug remdesivir to treat patients with COVID-19.

...

Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
By Pankaj Singh

Bharat Biotech International, a leading Indian biotechnology company, has reportedly announced that its potential coronavirus vaccine, Covaxin, has received Drug Controller General of India (DCGI) approval to start hum...

Seattle Genetics reveals positive data from tisotumab vedotin trial
Seattle Genetics reveals positive data from tisotumab vedotin trial
By Pankaj Singh

Seattle Genetics, Inc., a renowned biotechnology firm that focuses on developing antibody-based cancer treatments, has recently revealed positive topline data from its Phase 2 clinical trial (innovaTV 204) assessing ti...